Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 362-368

  Patel, Pretesh R ^a   Yoo, Sua ^a   Broadwater, Gloria ^a   Marks, Lawrence B ^b   Miles, Edward F ^c   D'Amico, Thomas A ^a   Harpole, David ^a   Kelsey, Chris R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEST WALL; CLINICAL OUTCOME; CONTROL RATES; DISEASE FREE SURVIVAL; DUKE UNIVERSITY; GANTRY ANGLES; INTENSITY-MODULATED RADIATION THERAPY; KAPLAN-MEIER METHOD; LOCAL CONTROL; LUNG IRRADIATION; MALIGNANT PLEURAL MESOTHELIOMAS; MEAN LUNG DOSE; MEDIAN SURVIVAL; MEDICAL CENTER; NATIONAL CANCER INSTITUTE; OVERALL SURVIVAL RATES; PLANNING TARGET VOLUMES; PLEURAL SPACE; PULMONARY TOXICITY; TARGET COVERAGE; TARGET VOLUMES;

BIOLOGICAL ORGANS; CHEMOTHERAPY; DISEASE CONTROL; PATIENT MONITORING; PATIENT TREATMENT; TOXICITY; TUMORS;

PHYSICAL THERAPY;

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; GEMCITABINE; PEMETREXED;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DOSIMETRY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG RESECTION; LUNG TOXICITY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANCER CARE FACILITIES; CLINICAL COMPETENCE; FEMALE; HUMANS; LUNG; MALE; MESOTHELIOMA; MIDDLE AGED; NORTH CAROLINA; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84859879076     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.11.057     Document Type: Article

References (24)

1. A.S. Tsao, I. Wistuba, and J.A. Roth Malignant pleural mesothelioma J Clin Oncol 27 2009 2081 2090
2. V.W. Rusch, S. Piantadosi, and E.C. Holmes The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial J Thorac Cardiovasc Surg 102 1991 1 9
3. R.M. Flores, H.I. Pass, and V.E. Seshan Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients J Thorac Cardiovasc Surg 135 2008 620 626
4. H.I. Pass, K. Kranda, and B.K. Temeck Surgically debulked malignant pleural mesothelioma: results and prognostic factors Ann Surg Oncol 4 1997 215 222
5. T.W. Rice, D.J. Adelstein, and T.J. Kirby Aggressive multimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 58 1994 24 29
6. A. Ahamad, C.W. Stevens, and W.R. Smythe Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest Cancer J 9 2003 476 484
7. L.M. Krug, H.I. Pass, and V.W. Rusch Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma J Clin Oncol 27 2009 3007 3013
8. M.T. Jaklitsch, S.C. Grondin, and D.J. Sugarbaker Treatment of malignant mesothelioma World J Surg 25 2001 210 217
9. A. Ahamad, C.W. Stevens, and W.R. Smythe Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma Int J Radiat Oncol Biol Phys 55 2003 768 775
10. K.M. Forster, W.R. Smythe, and G. Starkschall Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation Int J Radiat Oncol Biol Phys 55 2003 606 616
11. E.F. Miles, N.A. Larrier, and C.R. Kelsey Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience Int J Radiat Oncol Biol Phys 71 2008 1143 1150
12. D.C. Rice, W.R. Smythe, and Z. Liao Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma Int J Radiat Oncol Biol Phys 69 2007 350 357
13. D.C. Rice, C.W. Stevens, and A.M. Correa Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma Ann Thorac Surg 84 2007 1685 1692 discussion 1692-1693
14. A.M. Allen, M. Czerminska, and P.A. Janne Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma Int J Radiat Oncol Biol Phys 65 2006 640 645
15. D.S. Ettinger, W. Akerley, and H. Borghaei Malignant pleural mesothelioma. Clinical practice guidelines in oncology J Natl Compr Canc Netw 10 2012 26 41
16. X. Wang, X. Zhang, and L. Dong Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma Int J Radiat Oncol Biol Phys 63 2005 594 601
17. V.W. Rusch, and E.S. Venkatraman Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically Ann Thorac Surg 68 1999 1799 1804
18. E.H. Baldini, A. Recht, and G.M. Strauss Patterns of failure after trimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 63 1997 334 338
19. V.W. Rusch, K. Rosenzweig, and E. Venkatraman A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma J Thorac Cardiovasc Surg 122 2001 788 795
20. C.A. Kristensen, T.J. Nottrup, and A.K. Berthelsen Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma Radiother Oncol 92 2009 96 99
21. M.F. Muers, R.J. Stephens, and P. Fisher Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial Lancet 371 2008 1685 1694
22. N.J. Vogelzang, J.J. Rusthoven, and J. Symanowski Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 2003 2636 2644
23. W. Weder, R.A. Stahel, and J. Bernhard Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma Ann Oncol 18 2007 1196 1202
24. D.J. Sugarbaker, R.M. Flores, and M.T. Jaklitsch Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 1999 54 63 discussion 63-65